The Race to Supercharge Cancer-Fighting T Cells
The Race to Supercharge Cancer-Fighting T Cells
Nature—Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, and his colleagues have been using CRISPR to increase the therapeutic potential of T cells. This work is part of a worldwide effort to improve the design and manufacturing of cancer-killing ‟CAR-T” cells reviewed in the journal Nature.
Gladstone Experts Cancer Genomic Immunology Marson Lab CRISPR/Gene Editing